Cuál es el precio por D. Western Therapeutics Institute, Inc. (4576)

Precio por D. Western Therapeutics Institute, Inc. (4576) es de$0.5676202

Cuál es la capitalización de mercado por D. Western Therapeutics Institute, Inc. (4576)

Capitalización de mercado por D. Western Therapeutics Institute, Inc. (4576) es $32.62M

D. Western Therapeutics Institute, Inc. (4576) Acciones en Circulación

D. Western Therapeutics Institute, Inc. is a biotechnology enterprise focused on the research, discovery, and innovation of various pharmaceutical drugs. The company's current portfolio includes GLANATEC and GLA-ALPHA, ophthalmic solutions prescribed for glaucoma and ocular hypertension, as well as DW-1001, another medication for eye conditions. It also provides DWR-2206, a regenerative cell-based product targeting bullous keratopathy, and DW-1002, an ophthalmic surgical aid used for staining membranes like ILM, ALC, ERM, and PVR during cataract operations. In its development pipeline, the company is advancing DW-5LBT, a lidocaine patch designed to alleviate neuropathic pain post-shingles. Additionally, K-321 is progressing through Phase III clinical trials for Fuch endothelial corneal dystrophy, and H-1337, a multi-kinase inhibitor, has commenced Phase IIb trials for glaucoma and ocular hypertension treatment. The firm was established in 1999 and operates from its headquarters in Nagoya, Japan.

Año	Acciones en circulación	Cambiar
Not enough data for the provided dates.

Año

Acciones en circulación

Cambiar

Not enough data for the provided dates.

Empresa	Acciones en circulación	Diferencia	País
Vertex Pharmaceuticals Incorporated VRTX.US	253.90M	-	US
Moderna, Inc. MRNA.US	396.00M	-	US
Argenx SE ARGX.US	62.19M	-	NL
CSL Limited CSL.AX	483.58M	-	AU
Lonza Group AG LONN.SW	-	-	CH

Empresa

Acciones en circulación

Diferencia

País